Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DNA microarray diagnostic market is set to reach $500m by 2010

This article was originally published in Clinica

Executive Summary

So far, only a smattering of clinical diagnostics firms are selling DNA microarray-based assays. But following advancements in the field, clinical DNA microarrays are now on the brink of a boom and are likely to generate a $500m niche market in just two years time, according to Bertrand Jordan, founder and former head of genetics consortium Genopole, and scientific consultant for three microarray companies. Clinica's Claire Thomas caught up with Dr Jordan shortly after the recent Advances in Microarray Technology Conference in Edinburgh, Scotland

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048929

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel